🇺🇸 FDA

Company profile · Sponsor

CNS

CNS Pharmaceuticals

CNSP · NYSE pharma HOUSTON, TX, USA
Pipeline
21
Drugs
0
Patents
0

Quick answer

CNS (CNSP) is a pharma company. headquartered in HOUSTON, TX, USA. listed on NYSE. NovaPharmaNews links 21 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CNSP
Exchange NYSE
Company type pharma
Headquarters HOUSTON, TX, USA
SEC CIK 0001729427

Pipeline (21)

Search pipeline →

  1. Transcranial Magnetic stimulation

    CNS

    Gambling Disorder

    phase 3 other active

    1 trial

  2. Berubicin

    CNS

    Glioblastoma Multiforme, Adult

    phase 2 small molecule active

    1 trial

  3. Berubicin hydrochloride, Cecenu® 40 mg Kapsel

    CNS

    Glioblastoma multiforme (GBM)

    phase 2 small molecule active

    1 trial

  4. CTX-4430

    CNS

    Acne Vulgaris

    phase 2 small molecule completed

    1 trial

  5. DSM265

    CNS

    Malaria

    phase 2 small molecule terminated

    2 trials

  6. Estradiol , estriol , progesterone

    CNS

    Menopause

    phase 2 small molecule terminated

    1 trial

  7. MMV390048 40mg

    CNS

    Malaria

    phase 2 small molecule completed

    1 trial

  8. OZ439

    CNS

    Malaria

    phase 2 small molecule completed

    1 trial

  9. Paclitaxel

    CNS

    Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  10. Sertraline+Antibiotic (penicillin/azithromycin)

    CNS

    Pandas

    phase 2 small molecule terminated

    1 trial

  11. rTMS (repetitive transcranial magnetic stimulation)

    CNS

    Obsessive-Compulsive Disorder

    phase 2 other active

    1 trial

  12. vitamin C

    CNS

    Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  13. (+)-SJ000557733

    CNS

    Plasmodium Falciparum Malaria

    phase 1 small molecule completed

    1 trial

  14. 480 mg Piperaquine phosphate

    CNS

    Malaria

    phase 1 small molecule completed

    1 trial

  15. ALPN-101

    CNS

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  16. Administration of the malaria inoculum

    CNS

    Malaria

    phase 1 mab completed

    1 trial

  17. DAB

    CNS

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  18. Intravenous Vitamin C

    CNS

    Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

  19. MMV390048 40 mg

    CNS

    Malaria

    phase 1 small molecule completed

    1 trial

  20. PRA

    CNS

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  21. SPR206

    CNS

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is CNS?

CNS (CNSP) is a pharma company. headquartered in HOUSTON, TX, USA. listed on NYSE. NovaPharmaNews links 21 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does CNS sponsor?

We track 21 ClinicalTrials.gov-linked programs for CNS, including Transcranial Magnetic stimulation and 20 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does CNS company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.